Can liquid biopsy revolutionize cancer treatment?
One innovation in diagnostic technology is paving the way for huge shifts in the way experts diagnose, monitor and treat diseases — especially cancer.
One innovation in diagnostic technology is paving the way for huge shifts in the way experts diagnose, monitor and treat diseases — especially cancer.
Researchers have discovered a way of measuring the interaction between cancer cells and immune cells in the human body.
Why do cancer cells often bypass the immune system’s gatekeeper? New study finds a possible answer in cellular waste-processing machinery.
Hadassah Medical Center reports that trials of a groundbreaking CAR-T therapy showed a nearly 90% response rate in 74 patients.
Israeli synthetic biologist helps a US startup design switches that engineer immune cells right inside the body for faster, less expensive treatment.
OncoHost’s prediction platform is geared to help physicians choose the best chemo or immunotherapy for each patient, rather than the hit and miss ‘one size fits all.’
Israeli and Portuguese researchers develop tiny synthetic molecules that can penetrate less accessible areas of tumors and could be taken orally.
NeoTX, whose team includes several Nobel laureates, is testing a cancer-fighting approach that uses bacteria to bait the immune system into an attack.
‘Our unique ability to generate pre-clinical HNC models and to investigate new treatment and treatment combinations provides hope for HNC patients.’
Researchers have developed an immunotherapy platform that inhibits melanoma using TRAIL proteins and NanoGhost technology as a drug-delivery vehicle.
Study finds certain immune cells sometimes ‘switch sides’ and actually help tumors grow; finding has implications for improving immunotherapy
Study suggests the possibility of ‘off-the-shelf’ immunotherapies in which T cell receptors that recognize cancer hotspots can be prepared in advance.
New study shows eosinophils can be summoned to fight cancer by destroying the cancer cells directly and by recruiting T-cells to help.
Nectin Therapeutics creates a roadblock to stop cancer cells evading immunotherapy treatments, boosting the success of the therapy.
With the immune system, what we don’t know far outweighs what we do. An Israeli startup aims to fill in those all-important gaps.